SEC Form D · filed March 22, 2019
CYTIMMUNE SCIENCES INC
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (23)
Hidetaka K. Itani · ROCKVILLE, MDDirectorGary D. Rosenfeld · ROCKVILLE, MDExecIra S. Shapiro · ROCKVILLE, MDDirectorMarc S. Stanley · ROCKVILLE, MDDirectorDavid M. Oarr · ROCKVILLE, MDExecJohn W. Holaday · Gaithersburg, MDDirectorMitchell S. Marder · ROCKVILLE, MDExecLawrence Tamarkin · ROCKVILLE, MDExec · DirectorGeoffrey J. Von Maltzahn · SEATTLE, WADirectorPatrick J. Yang · SEATTLE, WADirectorDonald J. Payan · SEATTLE, WAExecDouglas J. Cole · SEATTLE, WAExecRichard J. Mulligan · SEATTLE, WADirectorNeal W. Cohne · ROCKVILLE, MDDirectorAndrew R. Brown · SAN FRANCISCO, CADirectorAndrew R. Kowal · SAN FRANCISCO, CAExecPeter R. Christodoulo · SAN FRANCISCO, CAExecEzra R. Perlman · SAN FRANCISCO, CADirectorDeep R. Shah · SAN FRANCISCO, CADirectorJohn W. Holaday · Bedminster, NJDirectorMitchell S. Marder · ROCKVILLE, MDExecNeal W. Cohne · ROCKVILLE, MDDirectorLawrence Tamarkin · ROCKVILLE, MDExec · Director Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗